Background
PFO, epileptic seizures, epilepsy, hypoxia, cerebral neurological dysfunction
HYPOXIA, EPILEPTIC SEIZURE, EPILEPSY
A significant proportion of patients with epilepsy have an unknown etiology and lack effective targeted therapeutic drugs. Patent Foramen Ovale (PFO) induces hypoxia and microembolism, leading to cerebral neurological dysfunction and increased epilepsy risk. This study aims to assess the efficacy and safety of PFO closure for relieving epileptic seizures in patients with refractory epilepsy associated with PFO.